Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.040
+0.020 (0.99%)
At close: Oct 9, 2026, 4:00 PM EDT
2.050
+0.010 (0.49%)
After-hours: Oct 9, 2026, 5:34 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $80.48 million as of October 9, 2026. It is the 26,976th most valuable company in the world and the 4,314th biggest in the United States. Its market cap has decreased by 32.88% in one year.
Market Cap
80.48M
Enterprise Value
3.22M
1-Year Change
-32.88%
Global Rank
Country Rank
#4,314 United States
Category
ChartMarket Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $80.48M, a decrease of -83.51%. That is a compound annual growth rate of -29.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 80.48M | -29.32% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lucid Diagnostics | 121.83M |
| Apyx Medical | 109.10M |
| MaxCyte | 104.24M |
| Hyperfine | 98.70M |
| electroCore | 87.09M |
| Pulmonx | 79.02M |
| LENSAR | 78.26M |
| Outset Medical | 76.13M |